Monitoring serum chorionic gonadotropin levels after mifepristone abortion

Contraception

Volumn 64, Issue 5, 2001, Pages 271-273

  Walker, Kym ^a   Schaff, Eric ^a   Fielding, Stephen ^a   Fuller, Lisa ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; MIFEPRISTONE; MISOPROSTOL;

ABORTION; CLINICAL ARTICLE; CONTROLLED STUDY; COST UTILITY ANALYSIS; DISEASE MARKER; DRUG ACTIVITY; DRUG EFFICACY; ECTOPIC PREGNANCY; FEMALE; GONADOTROPIN BLOOD LEVEL; HEALTH CARE COST; HUMAN; NOTE; PREGNANCY TEST; ULTRASOUND; VAGINA BLEEDING;

ABORTIFACIENT AGENTS; ABORTION, INDUCED; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; MIFEPRISTONE; MONITORING, PHYSIOLOGIC; PREGNANCY; TIME FACTORS;

EID: 0035691037     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(01)00266-9     Document Type: Article

References (10)

1. Highlights of trends in pregnancies and pregnancy rates by outcome: Estimates for the United States, 1976-96
2. A 26-year-old woman seeking an abortion (Clinical Crossroads: Conferences with patients, and doctors)
3. Analysis of 369 abortions conducted by mifepristone (RU486) associated with sulprostone in a French family planning center
4. Combined methotrexate and misoprostol for early induced abortion
5. Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol
6. Methotrexate and misoprostol for abortion at 57-63 days gestation
7. Methotrexate and misoprostol vs. misoprostol alone for early abortion: A randomized controlled trial
8. The disappearance of human chorionic gonadotropin from plasma, and urine following induced abortion
9. Low-dose mifepristone followed by vaginal misoprostol at 48 h for abortion up to 63 days
10. Low-dose mifepristone 200 mg and vaginal misoprostol for induced abortion